[Maintenance chemotherapy for ovarian adenocarcinoma with carboquone: doses and side effects (author's transl)]

Nihon Sanka Fujinka Gakkai Zasshi. 1982 May;34(5):634-6.
[Article in Japanese]
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / enzymology
  • Adenocarcinoma, Mucinous / drug therapy
  • Adenocarcinoma, Mucinous / enzymology
  • Adult
  • Alanine Transaminase / blood
  • Alkaline Phosphatase / blood
  • Aspartate Aminotransferases / blood
  • Azirines / administration & dosage*
  • Carbazilquinone / administration & dosage*
  • Carbazilquinone / adverse effects
  • Cystadenocarcinoma / drug therapy
  • Cystadenocarcinoma / enzymology
  • Female
  • Humans
  • Leukocyte Count
  • Middle Aged
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / enzymology
  • Prognosis

Substances

  • Azirines
  • Carbazilquinone
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Alkaline Phosphatase